Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post‐transplant Clinical Outcome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of Bridging Locoregional Therapies for Hepatocellular Carcinoma on Post‐transplant Clinical Outcome

Published:2020-11-20 Issue:12 Volume:34 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Adeniji Nia¹^ORCID,Arjunan Vinodhini²,Prabhakar Vijay³,Tulu Zeynep⁴,Kambham Neeraja⁵,Ahmed Aijaz²,Kwo Paul²,Dhanasekaran Renumathy²^ORCID

Affiliation:

1. Stanford University School of Medicine Stanford CA USA

2. Division of Gastroenterology and Hepatology Stanford University Stanford CA USA

3. Division of Gastrointestinal and Liver Diseases Keck School of Medicine of USC Los Angeles CA USA

4. Stanford Hospital and Clinics Stanford CA USA

5. Department of Pathology Stanford University Stanford CA USA

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14128

Reference16 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990‐2017

3. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States

4. More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma

5. Effect of Mandatory 6‐Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study;BJS Open;2024-07-02

2. Long‐term posttransplant survival outcome following bridging locoregional therapy in hepatocellular carcinoma patients: A systematic review and meta‐analysis;JGH Open;2024-07

3. Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis on intention‐to‐treat outcomes;Journal of Hepato-Biliary-Pancreatic Sciences;2022-10-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3